585 related articles for article (PubMed ID: 30099826)
1. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Zhao X; Li X; Zhou L; Ni J; Yan W; Ma R; Wu J; Feng J; Chen P
Cancer Sci; 2018 Oct; 109(10):3068-3079. PubMed ID: 30099826
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
3. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
[TBL] [Abstract][Full Text] [Related]
4. The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Chen W; Li X; Du B; Cui Y; Ma Y; Li Y
Cancer Med; 2023 Feb; 12(4):4421-4433. PubMed ID: 35924724
[TBL] [Abstract][Full Text] [Related]
5. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
[TBL] [Abstract][Full Text] [Related]
6. HOXA11-AS regulates JAK-STAT pathway by miR-15a-3p/STAT3 axis to promote the growth and metastasis in liver cancer.
Wang S; Zhang S; He Y; Huang X; Hui Y; Tang Y
J Cell Biochem; 2019 Sep; 120(9):15941-15951. PubMed ID: 31099097
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PCAT6 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of lung adenocarcinoma cell by targeting miR-545-3p.
Yang C; Huang H; Li Y; Zhuo T; Zhu L; Luo C; Wu Y; Qin S
Mol Biol Rep; 2023 Apr; 50(4):3557-3568. PubMed ID: 36787056
[TBL] [Abstract][Full Text] [Related]
8. SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.
Wei Y; Wei L; Li J; Ma Z; Zhang Q; Han Z; Li S
Cancer Med; 2020 Oct; 9(19):7205-7217. PubMed ID: 32762035
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
[TBL] [Abstract][Full Text] [Related]
10. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
11. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
12. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
Liu L; Liu L; Lu S
Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209
[TBL] [Abstract][Full Text] [Related]
13. lncRNA CYTOR promotes lung adenocarcinoma gemcitabine resistance and epithelial-mesenchymal transition by sponging miR-125a-5p and upregulating ANLN and RRM2.
Cao Q; Wang H; Zhu J; Qi C; Huang H; Chu X
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):210-222. PubMed ID: 38273783
[TBL] [Abstract][Full Text] [Related]
14. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
Xu C; He T; Li Z; Liu H; Ding B
Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
[TBL] [Abstract][Full Text] [Related]
15.
Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W
Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
Lin FJ; Lin XD; Xu LY; Zhu SQ
Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
[TBL] [Abstract][Full Text] [Related]
17. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
Huang Q; Xing S; Peng A; Yu Z
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
[TBL] [Abstract][Full Text] [Related]
18. ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.
Ying K; Wang L; Long G; Lian C; Chen Z; Lin W
Cell Biol Int; 2020 Dec; 44(12):2438-2449. PubMed ID: 32808728
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.
Yang JX; Liu B; Yang BY; Meng Q
Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]